Helixmith Co., Ltd (KOSDAQ:084990)
6,060.00
+50.00 (0.83%)
At close: Feb 6, 2026
Helixmith Market Cap
Helixmith has a market cap or net worth of 279.04 billion as of February 6, 2026. Its market cap has increased by 108.97% in one year.
Market Cap
279.04B
Enterprise Value
196.73B
Revenue
3.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,060.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 279.04B, an increase of 16.93%. That is a compound annual growth rate of 0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 279.04B | -2.57% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 480.90B |
| Anterogen.Co.,Ltd. | 401.24B |
| JETEMA, | 337.03B |
| Bioneer | 336.05B |
| EASY BIO,Inc. | 248.78B |
| HLB Therapeutics | 247.25B |
| Genexine | 210.57B |
| MedPacto | 201.19B |